Valnoctamide
Valnoctamide (Valmethamide), a derivative of valproate, suppresses benzodiazepine-refractory status epilepticus. Valnoctamide (Valmethamide) acts directly on GABAA receptors[1].
Product Specifications
CAS Number
[4171-13-5]
Product Name Alternative
Valmethamide
UNSPSC
12352211
Hazard Statement
H302
Target
GABA Receptor
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/valnoctamide.html
Concentration
10mM
Purity
99.0
Solubility
DMSO : ≥ 100 mg/mL
Smiles
CCC(C(C(N)=O)CC)C
Molecular Formula
C8H17NO
Molecular Weight
143.23
Precautions
H302
References & Citations
[1]Spampanato J, et al. Valnoctamide enhances phasic inhibition: a potential target mechanism for the treatment of benzodiazepine-refractory status epilepticus. Epilepsia. 2014 Sep;55 (9) :e94-8.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 3
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6304924-01 0.2 mL
GTF2IRD2B, CT (GTF2IRD2B, General transcription factor II-I repeat domain-containing protein 2B, Transcription factor GTF2IRD2-beta) (FITC)
Ask
View Details 
MBS6304924-02 5x 0.2 mL
GTF2IRD2B, CT (GTF2IRD2B, General transcription factor II-I repeat domain-containing protein 2B, Transcription factor GTF2IRD2-beta) (FITC)
Ask
View Details 
